ABCB1 and leukemia: Although the circulating concentration of CLCs varied by at least 1000-fold over the 3-week time course of disease (Supplemental Fig. 1a), we observed no significant correlation between days post leukemia initiation and either half-life or fraction remaining (Supplemental Fig. 1b, c), suggesting that the early and later stage CLCs have similar circulation properties in both models.